Back to results
CompletedPhase 1

A Study to Evaluate the Safety and Dosimetry of 68Ga-labelled OncoFAP Derivatives in Solid Tumors

NCT05784597

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Istituto Nazionale dei Tumori | Fondazione IRCCS

Milan, Milano, Italy

+4 additional locations

View on ClinicalTrials.gov
A Study to Evaluate the Safety and Dosimetry of 68Ga-labelled OncoFAP Derivatives in Solid Tumors — TrialFind